Real World Study of MPM in China
Launched by CHINESE ACADEMY OF MEDICAL SCIENCES · Sep 5, 2021
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pathologically confirmed as malignant pleural mesothelioma
- • Aged over 18
- Exclusion Criteria:
- • Follow-up less than 3 months
About Chinese Academy Of Medical Sciences
The Chinese Academy of Medical Sciences (CAMS) is a premier national institution dedicated to advancing medical research and healthcare in China. As a leading sponsor of clinical trials, CAMS focuses on innovative therapies, disease prevention, and public health initiatives. With a robust infrastructure that encompasses research hospitals, laboratories, and collaboration with international partners, CAMS aims to enhance the translation of scientific discoveries into clinical practice. Their commitment to rigorous scientific standards and ethical conduct ensures the integrity and reliability of the trials they sponsor, ultimately contributing to improved health outcomes both domestically and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Zhouguang Hui, Ph.D.
Principal Investigator
Chinese Academy of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials